Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
- Status
- RECRUITING
- Phase
- PHASE1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Status
- RECRUITING
- Phase
- N/A
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PTCy and ATG for MSD and MUD Transplants
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
The Pathogenesis and Prognostic Factors of Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Status
- RECRUITING
- Phase
- PHASE2